Nizar Asadi

Royal Brompton & Harefield NHS Foundation Trust

Nizar is a Consultant Thoracic Surgeon with special interest in minimal invasive surgery. He trained in thoracic surgery in several hospitals including Royal
Brompton, Harefield and Great Ormond Street Hospital. He completed his CCT in Italy in the University of Bologna in 2014; following that he moved to UK and completed multiple fellowships in Thoracic and tracheal Surgery. He was recently appointed as Thoracic Consultant in Harefield Hospital, one of the worlds leading hospitals for cardiothoracic surgery. He is a researcher and currently leading multiple projects in thoracic adult and paediatric surgery, with a special interest in quality of life and enhanced recovery after surgery. He has presented and lectured at multiple national and international conferences and currently is an active member of the European Society of Thoracic Surgeons.

dont miss

Thoracic surgery in the treatment of lung cancer

Lung cancer is the most frequent cause of cancer-related deaths worldwide. 20% of patients diagnosed with lung cancer will be a candidate for radical surgical treatment. Surgery currently is the gold-standard treatment for early stages of lung cancer; however with introducing new treatments the role of surgery is becoming more limited. How do those evolutions affect the role of surgery in the treatment of lung cancer? How Thoracic surgery is evolving with the new technologies?

EVEN MORE SEMINARS

  • Stéfan Halbherr: Speaking at the Oncology Convention

    Stéfan Halbherr
    InnoMedica

    Liposome pipeline addressing unmet medical needs in oncology, imaging, and neurodegeneration

  • Michael Schreiber: Speaking at the Oncology Convention

    Michael Schreiber
    Brain Tumor Foundation, Chairman

    Brain Tumors - Innovation, support and advocacy

  • Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath: Speaking at the Oncology Convention

    Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath
    University Hospital Southampton NHS Foundation Trust.

    Targeted therapies: aiming at the tumour micro-environment

  • Dr Ndaba Mazibuko: Speaking at the Oncology Convention

    Dr Ndaba Mazibuko
    Care Oncology Clinic, Kings College London

    Drug Repurposing In Practice: Metabolic Pleiotropism in Glioblastoma Management

  • Laura Allington: Speaking at the Oncology Convention

    Laura Allington
    University College London Hospitals NHS Foundation Trust

    Operational challenges of planning a new NHS high energy proton service.